Comparative effectiveness of ustekinumab vs. vedolizumab for anti-TNF-naïve or anti-TNF-exposed Crohn's disease: a multicenter cohort studyResearch in context

Summary: Background: Ustekinumab and vedolizumab are both effective for treating Crohn’s disease (CD). However, no head-to-head trials have been conducted thus far. We aimed to compare the effectiveness of ustekinumab and vedolizumab in CD patients either naïve or exposed to tumor necrosis factor-a...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Hongsheng Yang, Zhaopeng Huang, Miao Li, Haiyan Zhang, Lingyu Fu, Xiaoling Wang, Qiaoqiao Yang, Yun He, Wenhong Wu, Taofeng Jiang, Zhimei Sun, Tao Zhang, Dongping Lai, Xixin Wu, Lishuo Shi, Qin Guo, Yanhui Wu, Jian Tang, Kang Chao, Xiang Gao
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2023-12-01
סדרה:	EClinicalMedicine
נושאים:	Crohn’s disease ustekinumab vedolizumab
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S258953702300514X
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!